FindTrial
Sign In

SCRT

RADIATION8 trials

Sponsors

Korea Health Industry Development Institute, Kyung Hee University Hospital at Gangdong, Fujian Cancer Hospital, National Cancer Center Hospital East, Zhejiang Cancer Hospital

Conditions

Colorectal CancerLocally Advanced Rectal CancerPerennial Allergic RhinitisRadiationRectal CancerRectal Cancer, AdenocarcinomaToripalimabUpper Respiratory Tract Infections

Phase 2

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy
Not yet recruitingNCT05640726
Fujian Cancer HospitalRectal Cancer
Start: 2023-05-01End: 2026-05-01Target: 30Updated: 2022-12-07
SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC
RecruitingNCT06516445
Huazhong University of Science and TechnologyColorectal Cancer
Start: 2023-06-28End: 2026-06-28Target: 33Updated: 2024-07-24
Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
RecruitingNCT07154316
Fudan UniversityColorectal Cancer
Start: 2025-08-01End: 2028-12-30Target: 138Updated: 2025-09-04

Phase 3

Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection
CompletedNCT01019889
Korea Health Industry Development InstituteUpper Respiratory Tract Infections
Start: 2008-09-30End: 2009-07-31Updated: 2012-04-06
Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis
NCT03009136
Kyung Hee University Hospital at GangdongPerennial Allergic Rhinitis
Start: 2016-12-31End: 2018-12-31Target: 154Updated: 2017-03-14
TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer
RecruitingNCT05646511
National Cancer Center Hospital EastLocally Advanced Rectal Cancer
Start: 2022-11-21End: 2030-12-31Target: 608Updated: 2025-04-03
A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status
NCT05669092
Zhejiang Cancer HospitalRadiation, Toripalimab
Start: 2022-11-01End: 2025-12-31Target: 174Updated: 2022-12-30

Unknown Phase

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
RecruitingNCT07474103
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRectal Cancer, Adenocarcinoma
Start: 2025-11-30End: 2028-12-31Target: 49Updated: 2026-03-16

Related Papers

No operation after short-course radiotherapy followed by consolidation chemotherapy in locally advanced rectal cancer (NOAHS-ARC): study protocol for a prospective, phase II trial.
2025-03-181 citations
Protocol amendment for ENSEMBLE study: A multicenter, randomized, phase III trial to test the superiority of consolidation irinotecan, capecitabine and oxaliplatin vs capecitabine and oxaliplatin following short course radiotherapy as total neoadjuvant therapy in patients with locally advanced rectal cancer—Changing the irinotecan dosage.
Journal of Clinical Oncology2024-08-101 citations
A prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in JAPAN: ENSEMBLE-1 study.
Journal of Clinical Oncology2024-01-20
Anus preservation in low rectal adenocarcinoma based on MMR/MSI status (APRAM): a study protocol for a randomised, controlled, open-label, multicentre phase III trial.
2024-01-104 citations
Efficacy and safety of So-Cheong-Ryong-Tang in treatment of perennial allergic rhinitis: study protocol for a double-blind, randomised, parallel-group, multicentre trial
BMJ Open2017-09-019 citations